Cited by 1,174Psoriasis: Treatment and PathogenesisT-cell and B-cell ImmunologyIL-33, ST2, and ILC Pathways

Induction and molecular signature of pathogenic TH17 cells

Open access
Lee, Youjin, Awasthi, Amit, Yosef, Nir, Quintana, Francisco J, Xiao, Sheng, Peters, Anneli, Wu, Chuan, Kleinewietfeld, Markus +5 more·2012·Nature Immunology

Abstract

Interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) are often present at the sites of tissue inflammation in autoimmune diseases, which has led to the conclusion that T(H)17 cells are main drivers of autoimmune tissue injury. However, not all T(H)17 cells are pathogenic; in fact, T(H)17 cells generated with transforming growth factor-β1 (TGF-β1) and IL-6 produce IL-17 but do not readily induce autoimmune disease without further exposure to IL-23. Here we found that the production of TGF-β3 by developing T(H)17 cells was dependent on IL-23, which together with IL-6 induced very pathogenic T(H)17 cells. Moreover, TGF-β3-induced T(H)17 cells were functionally and molecularly distinct from TGF-β1-induced T(H)17 cells and had a molecular signature that defined pathogenic effector T(H)17 cells in autoimmune disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ni.2416

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. [1]Abbas AK Murphy KM Sher A Functional diversity of helper T lymphocytes Nature 1996 383 787 793 8893001
  2. [2]Szabo SJ A novel transcription factor, T-bet, directs Th1 lineage commitment Cell 2000 100 655 669 10761931
  3. [3]Szabo SJ Sullivan BM Peng SL Glimcher LH Molecular mechanisms regulating Th1 immune responses Annu Rev Immunol 2003 21 713 758 12500979
  4. [5]Mosmann TR Coffman RL TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties Annu Rev Immunol 1989 7 145 173 2523712
  5. [6]Kuchroo VK T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire Annu Rev Immunol 2002 20 101 123 11861599
  6. [7]Ferber IA Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE) J Immunol 1996 156 5 7 8598493
  7. [8]Wildbaum G Youssef S Grabie N Karin N Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis J Immunol 1998 161 6368 6374 9834127
  8. [9]Bettelli E Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis J Exp Med 2004 200 79 87 15238607 PMC2213316
  9. [11]Bettelli E Korn T Oukka M Kuchroo VK Induction and effector functions of T(H)17 cells Nature 2008 453 1051 1057 18563156 PMC6280661
  10. [12]Mangan PR Transforming growth factor-beta induces development of the T(H)17 lineage Nature 2006 441 231 234 16648837
  11. [14]Korn T Bettelli E Oukka M Kuchroo VK IL-17 and Th17 Cells Annu Rev Immunol 2009 27 485 517 19132915
  12. [16]Awasthi A Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells J Immunol 2009 182 5904 5908 19414740 PMC2702203
  13. [18]McGeachy MJ The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo Nat Immunol 2009 10 314 324 19182808 PMC2945605
  14. [19]Duerr RH A genome-wide association study identifies IL23R as an inflammatory bowel disease gene Science 2006 314 1461 1463 17068223 PMC4410764
  15. [20]Rahman P Association of interleukin-23 receptor variants with ankylosing spondylitis Arthritis Rheum 2008 58 1020 1025 18383363
  16. [21]McGeachy MJ TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology Nat Immunol 2007 8 1390 1397 17994024
  17. [23]Esplugues E Control of TH17 cells occurs in the small intestine Nature 475 514 518 21765430 PMC3148838
  18. [24]Yang Y T-bet is essential for encephalitogenicity of both Th1 and Th17 cells J Exp Med 2009 206 1549 1564 19546248 PMC2715092
  19. [27]McQualter JL Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis J Exp Med 2001 194 873 882 11581310 PMC2193476
  20. [28]Yang LT Li WY Kaartinen V Tissue-specific expression of Cre recombinase from the Tgfb3 locus Genesis 2008 46 112 118 18257072 PMC2430471
  21. [29]Lyons RM Miller DA Graycar JL Moses HL Derynck R Differential binding of transforming growth factor-beta 1, -beta 2, and -beta 3 by fibroblasts and epithelial cells measured by affinity cross-linking of cell surface receptors Mol Endocrinol 1991 5 1887 1896 1665203
  22. [30]Graycar JL Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2 Mol Endocrinol 1989 3 1977 1986 2628733
  23. [31]Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 967 971 20962846 PMC3108066
  24. [32]Veldhoen M Hocking RJ Flavell RA Stockinger B Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease Nat Immunol 2006 7 1151 1156 16998492
  25. [33]Hirota K Fate mapping of IL-17-producing T cells in inflammatory responses Nat Immunol 12 255 263 21278737 PMC3040235
  26. [34]O'Connor RA Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis J Immunol 2008 181 3750 3754 18768826 PMC2619513
  27. [35]Gocke AR T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity J Immunol 2007 178 1341 1348 17237380
  28. [36]Park IK Shultz LD Letterio JJ Gorham JD TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1 J Immunol 2005 175 5666 5674 16237056
  29. [37]Zhou L IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways Nat Immunol 2007 8 967 974 17581537
  30. [38]Walline CC Kanakasabai S Bright JJ IL-7Ralpha confers susceptibility to experimental autoimmune encephalomyelitis Genes Immun 12 1 14 20861865 PMC3024464
  31. [39]Liu X Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease Nat Med 16 191 197 20062065
  32. [40]Lundmark F Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis Nat Genet 2007 39 1108 1113 17660816
  33. [41]Gregory SG Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis Nat Genet 2007 39 1083 1091 17660817
  34. [42]Veldhoen M The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins Nature 2008 453 106 109 18362914
  35. [43]Quintana FJ Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor Nature 2008 453 65 71 18362915
  36. [44]Bauquet AT The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and T(H)-17 cells Nat Immunol 2008 PMC2742982 19098919
  37. [45]Apetoh L The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27 Nat Immunol 11 854 861 20676095 PMC2940320
  38. [47]Awasthi A A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells Nat Immunol 2007 8 1380 1389 17994022
  39. [48]Reich M GenePattern 2.0 Nat Genet 2006 38 500 501 16642009
  40. [49]Irizarry RA Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 2003 4 249 264 12925520
  41. [50]Johnson WE Li C Rabinovic A Adjusting batch effects in microarray expression data using empirical Bayes methods Biostatistics 2007 8 118 127 16632515

Cited by

Sorted by citations

Authors
Lee, Y., Awasthi, A., Yosef, N., Quintana, F. J., Xiao, S., Peters, A., Wu, C., Kleinewietfeld, M., Kunder, S., Hafler, D. A., Sobel, R. A., Regev, A., & Kuchroo, V. K.
Affiliations
  • Brigham and Women's Hospital (US)
  • Broad Institute (US)
  • Yale University (US)
  • VA Palo Alto Health Care System (US)
Corresponding author
  • Awasthi, Amit
  • Kuchroo, Vijay K
Venue
Nature Immunology
Published
2012-09-09
Volume
13
Issue
10
Pages
991-999
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
OpenAlex
W2009675211
Cited by
1,174
References
9
Citations by year
2026: 45 · 2025: 65 · 2024: 76 · 2023: 88 · 2022: 96 · 2021: 114 · 2020: 74 · 2019: 73 · 2018: 96 · 2017: 109 · 2016: 92 · 2015: 83 · 2014: 84 · 2013: 71 · 2012: 6
FWCI
34.13
Type
journal article
Language
en
Open access
Locations
  • Nature Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • Howard Hughes Medical Institute
  • National Institutes of Health (DP1OD003958)
  • National Human Genome Research Institute (P01HG005062)
  • National Institute of Allergy and Infectious Diseases (R00AI075285, K99AI075285, R01AI093903, P01AI045757, P01AI073748, AI075285, AI073748, AI045757, R01AI091568, AI093903, R56AI093903, P01AI039671)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K01DK090105)
  • National Institute of Neurological Disorders and Stroke (R01NS030843, R29NS030843, NS030843, NS045937, R37NS030843, R01NS045937)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
IL-23, TGF-beta3, TGF-β1, IL-17, interleukin-6, autoimmune disease, molecular signatures, T cell differentiation, tissue inflammation
MeSH terms
Animals, Autoimmune Diseases, Cell Differentiation, Humans, Inflammation, Interleukin-6, Interleukin-17, Mice, Interleukin-23, Transforming Growth Factor beta1, Transforming Growth Factor beta3, Th17 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review